Methotrexate sodium and Basal cell carcinoma - from FDA reports


Summary

Basal cell carcinoma is found among people who take Methotrexate Sodium, especially for people who are female, 60+ old , have been taking the drug for 6 - 12 months, also take medication Folic Acid, and have Rheumatoid arthritis . We study 11,813 people who have side effects while taking Methotrexate sodium from FDA. Among them, 52 have Basal cell carcinoma. Find out below who they are, when they have Basal cell carcinoma and more.

What to expect?

If you take Methotrexate sodium and have Basal cell carcinoma, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Methotrexate sodium and have Basal cell carcinoma

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Methotrexate Sodium

Methotrexate sodium has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. (latest outcomes from Methotrexate sodium 13,112 users)

Basal Cell Carcinoma

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) has been reported by people with rheumatoid arthritis, osteoporosis, multiple sclerosis, high blood pressure, multiple myeloma (latest reports from 9,271 Basal cell carcinoma patients).

On Feb, 20, 2017

11,813 people reported to have side effects when taking Methotrexate Sodium.
Among them, 52 people (0.44%) have Basal Cell Carcinoma


Number of reports submitted per year:

Could Methotrexate sodium cause Basal cell carcinoma?

Time on Methotrexate Sodium when people have Basal Cell Carcinoma *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 10 %
  • 6 - 12 months: 60 %
  • 1 - 2 years: 10 %
  • 2 - 5 years: 20 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Basal Cell Carcinoma when taking Methotrexate Sodium *:

  • female: 65.96 %
  • male: 34.04 %

Age of people who have Basal Cell Carcinoma when taking Methotrexate Sodium *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 18.42 %
  • 50-59: 10.53 %
  • 60+: 71.05 %

Top conditions involved for these people *:

  • Rheumatoid Arthritis (35 people, 67.31%)
  • High Blood Pressure (11 people, 21.15%)
  • Osteoporosis (9 people, 17.31%)
  • Meniere's Disease (9 people, 17.31%)
  • Conjunctivitis Allergic (7 people, 13.46%)

Top co-used drugs for these people *:

  • Remicade (12 people, 23.08%)
  • Folic Acid (12 people, 23.08%)
  • Norvasc (10 people, 19.23%)
  • Micardis (9 people, 17.31%)
  • Enbrel (9 people, 17.31%)

Top other side effects for these people *:

  • Weight Decreased (6 people, 11.54%)
  • Pulmonary Embolism (6 people, 11.54%)
  • Neck Pain (6 people, 11.54%)
  • Drug Ineffective (6 people, 11.54%)
  • Anaemia (6 people, 11.54%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Basal cell carcinoma when taking Methotrexate sodium?

Browse all side effects of Methotrexate sodium

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Basal cell carcinoma

Basal cell carcinoma

Could your condition cause Basal cell carcinoma

Basal cell carcinoma

Related studies

Can you answer these questions?

More questions for: Methotrexate sodium, Basal cell carcinoma

You may be interested in these reviews

More reviews for: Methotrexate sodium, Basal cell carcinoma